Compare Sanofi SA (SNY) vs Workday Inc (WDAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sanofi SA vs Workday Inc — how do they compare? Sanofi SA trades at $43.12 (market cap $104.06B), while Workday Inc trades at $186.52 (market cap $44.89B). The key difference: Sanofi SA is far larger — about 2.3× Workday Inc's market cap, and Sanofi SA pays a 5.61% dividend while Workday Inc pays none. Which is the better fit depends on your goals.
| SNY | WDAY | |
|---|---|---|
Market Cap | $104.06B | $44.89B |
Sector | Health | Technology |
52-Week High | $52.34 | $247.69 |
52-Week Low | $41.33 | $112.55 |
Enterprise Value | $124.09B | $45.26B |
Dividend Yield | 5.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SNY trades at $43.16, down 2.45% today, with a bearish technical signal from moving averages but bullish oscillators. The company reported Q2 2026 EPS of $1.21, beating expectations, and raised its 2026 outlook driven by Dupixent strength. Financials show improved net income of $7.81B in 2025, with a P/E of 22.94 and net margin of 8.09%.
Outlook is mixed: strong drug performance and analyst hold ratings suggest stability, but pipeline setbacks and projected 2026 profit margin decline to 8.09% pose risks. The stock offers a 5.4% dividend yield, trading below sector P/E, presenting value if growth execution offsets challenges.
Workday (WDAY) trades at $186.28, down 4.86% today but has rallied 49.7% over three months on strong Q2 earnings beats and AI momentum. The stock shows bullish technical signals with support at $183 and resistance at $191. Fundamentally, revenue grew to $8.45B in 2025 with expanding margins, though valuation ratios remain elevated at P/E 37.94 and P/S 4.73. Recent news highlights Workday's eleventh consecutive leadership position in Gartner's HCM Magic Quadrant and growing AI adoption.
The outlook remains positive with analyst consensus at Buy (50.62%) and $204.52 price target, representing 9.8% upside. Key opportunities include AI-driven subscription growth and margin expansion, while risks involve competitive pressures from AI-native startups and execution challenges in sustaining profitability gains amid high valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →About Workday Inc
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →
